Coordinated Trigeminal and Vagal Nerve Stimulation for Industrial Applications

Publication ID: 24-11857788_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Coordinated Trigeminal and Vagal Nerve Stimulation for Industrial Applications,” Published Technical Disclosure No. 24-11857788_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857788_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,788.

Summary of the Inventive Concept

The inventive concept applies the core technology of coordinated trigeminal and vagal nerve stimulation to novel industrial applications, enhancing efficiency, reducing waste, and improving yields in agriculture, oil recovery, pollution reduction, and wastewater treatment.

Background and Problem Solved

The original patent focused on preventing and treating bleeding in humans. However, the underlying technology has broader potential. The inventive concept addresses the limitations of the original patent by exploring new industrial applications, where coordinated trigeminal and vagal nerve stimulation can be used to improve processes, reduce waste, and increase efficiency.

Detailed Description of the Inventive Concept

The inventive concept comprises systems and methods for applying coordinated trigeminal and vagal nerve stimulation to various industrial applications. In agriculture, the stimulation enhances photosynthesis and nutrient uptake, leading to improved crop yields. In oil recovery, the stimulation enhances oil degradation and increases oil flow. In pollution reduction, the stimulation optimizes biodegradation of pollutants. In wastewater treatment, the stimulation enhances biodegradation of organic matter and reduces sludge production. The systems and methods utilize plant-mounted or downhole apparatuses with at least two electrodes and a controller that coordinates stimulation of the trigeminal and vagal nerve pathways.

Novelty and Inventive Step

The new claims introduce a novel application of coordinated trigeminal and vagal nerve stimulation to industrial processes, which is non-obvious and distinct from the original patent's focus on human bleeding prevention and treatment.

Alternative Embodiments and Variations

Alternative embodiments may include different apparatus designs, electrode configurations, and stimulation protocols tailored to specific industrial applications. Variations may also include combining coordinated trigeminal and vagal nerve stimulation with other technologies, such as precision agriculture or advanced bioreactor systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, oil and gas, environmental remediation, and wastewater treatment. The market for these applications is substantial, with potential for widespread adoption and revenue growth.

Original Patent Information

Patent NumberUS 11,857,788
TitleMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Assignee(s)THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH